Efficacy of screening in preventing cervical cancer among older women
Although the effectiveness of cervical cancer screening has been firmly established in reproductive-age women, its usefulness in older women is unclear. We sought to evaluate the efficacy of cervical cancer screening in older women.
We conducted a case–control study within two integrated health care systems in the northwestern United States. Cases (n = 69) were women aged 55–79 years who were diagnosed with invasive cervical cancer during 1980–1999. Controls (n = 208) were women with an intact uterus and no diagnosis of cervical cancer, but otherwise similar to cases in terms of age and length of enrollment in the health plan. We reviewed medical records to ascertain screening history during the 7 years prior to reference date.
Compared to cases, controls were more likely to have received a Pap test. After adjustment for age and current smoking status, screening prior to an estimated 1-year duration of the occult invasive phase of cervical cancer was associated with a substantial reduction in risk [odds ratio (OR) 0.23; 95 % CI 0.11–0.44]. Similar results were obtained using different estimates of the duration of the occult invasive phase. Analysis of the relative incidence of invasive cervical cancer in relation to the time following a negative screening test suggested a large reduction during the first year (OR 0.09; 95 % CI 0.03–0.24). The incidence remained low for several years thereafter, returning to the incidence among unscreened women after 5–7 years.
Cervical cancer screening by means of cytology is highly efficacious in older women. Our findings also suggest that five-yearly screening is approximately as efficacious as more frequent screening.
KeywordsCervical cancer screening Cytology Pap smear Efficacy
- 14.Saslow D, Solomon D, Lawson HW et al (2012) American cancer society, American society for colposcopy and cervical pathology, and American society for clinical pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin 62:147–172PubMedCrossRefGoogle Scholar
- 15.American Congress of Obstetricians and Gynecologists (ACOG) (2012) Practice Bulletin No. 131: screening for cervical cancer. Obstet Gynecol 120:1222–1238Google Scholar
- 16.Surveillance Epidemiology and End Results. SEER Stat facts sheets: cervix uteri. [cited 2012 November 26]. Available from: http://seer.cancer.gov/statfacts/html/cervix.html#references
- 22.Berrino F, Gatta G, d’Alto M, Crosignani P, Riboli E (1986) Efficacy of screening in preventing invasive cervical cancer: a case-control study in Milan, Italy. IARC Sci Publ 111–23Google Scholar
- 23.IARC Working Group on Cervical Cancer Screening. Screening for squamous cervical cancer—the duration of low risk following negative results in cervical cytology test: introduction. IARC Sci Publ 1986:15–24Google Scholar
- 25.Schiffman MH, Brinton LA, Devesa SS, Fraumeni JF Jr (1996) Cervical cancer. In: Schottenfeld D, Fraumeni JF Jr (eds) Cancer epidemiology and prevention. Oxford University Press, New York, pp 1090–1116Google Scholar
- 39.Surveillance Epidemiology and End Results. Fast Stats. [cited 2012 November 26]; Available from: http://seer.cancer.gov/faststats/selections.php?series=cancer
- 40.American Cancer Society (2009) Cancer facts & figures 2009. Atlanta, American Cancer SocietyGoogle Scholar